Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ludovic Croxford

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
CNS Drugs|March 6, 2003
Therapeutic potential of cannabinoids in CNS diseaseJ Ludovic Croxford
Immunotherapy|July 20, 2010
Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategiesJ Ludovic Croxford, Takashi Yamamura
Nature Immunology|September 22, 2011
Damage control: how HIV survives the editor APOBEC3GJ Ludovic Croxford, Stephan Gasser
Journal of Neuroimmunology|July 19, 2005
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?J Ludovic Croxford, Takashi Yamamura
Drugs of Today (Barcelona, Spain : 1998)|October 29, 2004
Towards cannabis and cannabinoid treatment of multiple sclerosisJ Ludovic Croxford, Stephen D Miller
The Journal of Clinical Investigation|April 17, 2003
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212J Ludovic Croxford, Stephen D Miller
Molecular Immunology|March 24, 2004
Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicryJulie K Olson, J Ludovic Croxford, Stephen D Miller
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicryJ Ludovic Croxford, Holly A Anger, Stephen D Miller
Autoimmunity Reviews|July 10, 2003
Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosisJ Ludovic Croxford, Julie K Olson, Stephen D Miller
European Journal of Immunology|September 19, 2006
Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virusJ Ludovic Croxford, Anne M Ercolini, Mathew Degutes, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
CNS Drugs|March 6, 2003
Therapeutic potential of cannabinoids in CNS diseaseJ Ludovic Croxford
Immunotherapy|July 20, 2010
Back to the future for multiple sclerosis therapy: focus on current and emerging disease-modifying therapeutic strategiesJ Ludovic Croxford, Takashi Yamamura
Nature Immunology|September 22, 2011
Damage control: how HIV survives the editor APOBEC3GJ Ludovic Croxford, Stephan Gasser
Journal of Neuroimmunology|July 19, 2005
Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?J Ludovic Croxford, Takashi Yamamura
Drugs of Today (Barcelona, Spain : 1998)|October 29, 2004
Towards cannabis and cannabinoid treatment of multiple sclerosisJ Ludovic Croxford, Stephen D Miller
The Journal of Clinical Investigation|April 17, 2003
Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212J Ludovic Croxford, Stephen D Miller
Molecular Immunology|March 24, 2004
Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicryJulie K Olson, J Ludovic Croxford, Stephen D Miller
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicryJ Ludovic Croxford, Holly A Anger, Stephen D Miller
Autoimmunity Reviews|July 10, 2003
Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosisJ Ludovic Croxford, Julie K Olson, Stephen D Miller
European Journal of Immunology|September 19, 2006
Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virusJ Ludovic Croxford, Anne M Ercolini, Mathew Degutes, et al.
Pageof 3